AHA: AstraZeneca’s Farxiga outcomes data looks even better in patients without diabetes – FiercePharma

Seems AstraZeneca’s “paradigm racy” outcomes files for SLGT2 med Farxiga observe an even elevated cardiovascular earnings for sufferers who accomplish no longer own diabetes than those that make—and this for a drug designed specifically to treat the disease.
Read More

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button